A review on role of medicinal plants in HIV/AIDS therapy
Abstract
Human immune deficiency virus causes a potentially life threatening chronic disease called acquired immune deficiency syndrome by specifically suppressing immune system. More than 78 million people had been effected by since the pandemic and 39 million people died globally and 36.5 million people. If HIV is not treated it can leads to AIDS. There is no cure but it is treatable with medicine. The effective treatment with HIV medicine called antiretroviral therapy or ART is available. The antiretroviral drugs introduced in 1996 have been shown to increase oxidative stress among other drugs related complications. There is currently no effective cure. Once people get HIV they have if for life. People with AIDS have badly damaged immune system. The majority of the people living with HIV/AIDS are susceptible to bacterial and fungal opportunistic infections that results from immune suppression. Research throughout the world are trying to explore and develop more reliable and safe drugs from natural resourses to manage HIV infections. A wide range of medicinal plants have been studied and have reported significant potential against HIV. Plants like vernoniaamygdalina, rheu species, hypoxis hemerocallidea have high efficacy to cure HIV.The extraction of various phytoconstituents isolated from medicinal plants such as Alkaloids, flavanoids etc... have potential to interrupt the HIV.
References
2. Bokesch, H.R.; Wamiru, A.; Le Grice, S.F.J.; Beutler, J.A.; McKee, T.C.; McMahon, J.B. HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis.
3. Nyamwamu NC, Nyamwamu LB. An inventory of some medicinal plants used by abagusii traditional healers of South West Kenya. J. of Medicinal Plants Studies. 2020; 8(3):127-135
4. Kamatenesi MM, Acipa A, Oryem-Origa H. Medicinal plants of Otwal and Ngai Sub Counties in Oyam district, Northern Uganda. J Ethnobiol Ethnomed. 2011; 7:7 Noori S. 2012. An overview of oxidative stress and antioxidant defensive system. 1: 413. DOI: 10.4172/scientificreports.413 Mohamed A. H. 2011.
5. Rowley, D.C.; Hansen, M.S.; Rhodes, D.; Sotriffer, C.A.; Ni, H.; McCammon, J.A.; Bushman, F.D.; Fenical, W. Thalassiolins A-C: New marine-derived inhibitors of HIV cDNA integrase. Bioorgan. Med. Chem. 2002, 10, 3619–3625. [CrossRef]
6. Uppugalla S, Male U, Srinivasan P. Design and synthesis of heteroatoms doped carbon/polyaniline hybrid material for high performance electrode in supercapacitor application. Electrochimica Acta. 2014 Nov 10;146:242-8.
7. Male U, Uppugalla S, Srinivasan P. Effect of reduced graphene oxide–silica composite in polyaniline: electrode material for high-performance supercapacitor. Journal of Solid State Electrochemistry. 2015 Nov;19(11):3381-8.
8. Uppugalla S, Srinivasan P. High-performance supercapacitor coin cell: polyaniline and nitrogen, sulfur-doped activated carbon electrodes in aqueous electrolyte. Journal of Solid State Electrochemistry. 2019 Jan;23(1):295-306.
9. Uppugalla S, Srinivasan P. Polyaniline nanofibers and porous Ni [OH] 2 sheets coated carbon fabric for high performance super capacitor. Journal of Applied Polymer Science. 2019 Nov 5;136(41):48042.
10. Uppugalla S, Boddula R, Srinivasan P. Methyl triphenylphosphonium permanganate as a novel oxidant for aniline to polyaniline-manganese (II, IV) oxide: material for high performance pseudocapacitor. Journal of Solid State Electrochemistry. 2018 Feb;22(2):407-15.
11. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Sharifi-Rad, M.; Loizzo, M.R.; Ademiluyi, A.O. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules 2017, 22, 70. [CrossRef] [PubMed]
12. Kusumoto, I.T.; Nakabayashi, T.; Kida, H.; Miyashiro, H.; Hattori, M.; Namba, T.; Shimotohno, K. Screening of various plant-extracts used in ayurvedic medicine for inhibitory effects on human-immunodeficiency-virus type-1 (HIV-1) protease. Phytother. Res. 1995, 9, 180–184. [CrossRef]
13. Wang, Q.; Ding, Z.H.; Liu, J.K.; Zheng, Y.T. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antivir. Res. 2004, 64, 189–194. [CrossRef]
14. Valsaraj, R.; Pushpangadan, P.; Smitt, U.W.; Adsersen, A.; Christensen, S.B.; Sittie, A.; Nyman, U.; Nielsen, C.; Olsen, C.E. New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J. Nat. Prod. 1997, 60, 739–742. [CrossRef] [PubMed]
15. Prabhu S, Harwell JI, Kumarasamy N. Advanced HIV: diagnosis, treatment, and prevention. Lancet HIV. 2019;6:PE540-PE551.
16. Castro P, Torres B, Lopez A, et al. Effects of different antigenic stimuli on thymic function and interleukin-7/CD127 system in patients with chronic HIV infection. J Acquire Immune Deficiency Syndrome. 2014;66: 466-472
17. Aysun H. 2009. An overview of ascorbic acid biochemistry. Journal of Faculty of Pharmacy, Ankara 38(3): 233-255.
18. Abebe D. The role of medicinal plants in healthcare coverage of Ethiopia, the possible benefits of integration In: Conservation and sustainable use of medicinal plants in Ethiopia, Proceedings of the National workshop, 28 April – 01 May 1998.
19. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virusinfected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003;187(10):1534-1543.
20. Fatima A, Singh P, Agarwal P, Irchhaiya R, Alok S, Verma A. Treatment of various diseases by Carissa spinarum L.: A promising shrub. Int. J. Pharm. Sci. Res. 2013; 4:2489-2495.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
